期刊
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
卷 82, 期 5, 页码 1061-1082出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2019.08.089
关键词
adalimumab; antibiotics; hidradenitis; secukinumab; ustekinumab
类别
The treatment of hidradenitis suppurativa (HS) has remained challenging because of the many knowledge gaps regarding etiology. However, recent studies into the pathogenesis of HS have enabled the investigation of newer therapies. The second article in this continuing medical education series reviews the evidence for established therapies for HS, including anti-inflammatories, antibiotics, and surgery. New and emerging therapies that specifically target cytokines involved in HS pathogenesis will be covered. The potential therapeutic roles of anticytokine therapies, including both the expanded application of existing molecules as well as the specific development of novel therapies for HS are discussed. With increased attention on HS and with numerous clinical trials currently underway, we hope that the variety of treatment options for HS will be expanded.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据